Clinical Trial Update: Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

View source ↗

Summary

Clinical trial update indicates telpegfilgrastim injection is being studied to reduce chemotherapy-induced neutropenia in patients with solid tumors; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• Telpegfilgrastim (telpegfilgrastim)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Chemotherapy-induced Neutropenia | Status: RECRUITING